8-K - Akari Therapeutics Plc (0001541157) (Filer)
Published . Updated .
8-K - Akari Therapeutics filed an 8-K with the SEC on Oct 30 (a notice of a material company event).
Directly affected
- AKTX Akari Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AKTX | +10.64% | -2.25% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-30 AccNo: 0001493152-26-049446 Size: 251 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Akari Therapeutics (AKTX) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Akari Therapeutics (AKTX) | three days earlier | -2.25% | final price |
| Akari Therapeutics (AKTX) | five days earlier | +10.64% | final price |
Who gains and who loses around Akari Therapeutics (AKTX)
Companies tied to this story
- AKTX Akari Therapeutics
Akari Therapeutics (AKTX) is linked, with no stored direction, high confidence in the 30 Oct 2026 story “8-K - Akari Therapeutics Plc (0001541157) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> AKTX
How “8-K - Akari Therapeutics Plc (0001541157) (Filer)” reaches Akari Therapeutics (AKTX)
On 30 Oct 2026, “8-K - Akari Therapeutics Plc (0001541157) (Filer)” is the story that connects Akari Therapeutics (AKTX) to this story.
What ties Akari Therapeutics (AKTX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> AKTX
How solid “8-K - Akari Therapeutics Plc (0001541157) (Filer)” looks
14 out of 100
“8-K - Akari Therapeutics Plc (0001541157) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.